Serum levels of trace elements in patients with testicular cancers
dc.contributor.author | Kaba M. | |
dc.contributor.author | Pirinççi N. | |
dc.contributor.author | Yüksel M.B. | |
dc.contributor.author | Geçit I. | |
dc.contributor.author | Güneş M. | |
dc.contributor.author | Demir M. | |
dc.contributor.author | Akkoyun H.T. | |
dc.contributor.author | Demir H. | |
dc.date.accessioned | 2024-07-22T08:13:59Z | |
dc.date.available | 2024-07-22T08:13:59Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Introduction: Trace elements are primary components of biological structures; however, they can be toxic when their concentrations are higher than those needed for biological functions. Materials and Methods: In the present study serum levels of trace elements were measured in 30 patients (mean age was 26.9±11.2 years) newly diagnosed with germ cell testicular cancer and 32 healthy volunteers (mean age: 27.4±10.8) by using furnace atomic absorption spectrophotometer. Serum samples were stored at-20°C until assays. Results: In patients with germ cell testicular cancer, the diagnosis was seminoma in 15, mix germ cell tumor in 7, embryonal carcinoma in 4, yolk sac tumor in 2 and teratoma in 2 patients. There was stage I testicular tumor in 19 patients (63.3%) while stage II in 6 patients (20.0%), stage IIIA in 4 patients (13.3%) and stage IIIC in one patient (3.4%). It was found that serum Co, Cu, Mg and Pb levels were increased (p<0.05), whereas Fe, Mn, and Zn levels were decreased in patients with testicular cancer (p<0.05). Conclusions: These alterations may be important in the pathogenesis of testicular cancers; however, further prospective studies are needed to identify the relationship between testicular cancer and trace elements. | |
dc.identifier.DOI-ID | 10.1590/S1677-5538.IBJU.2014.0460 | |
dc.identifier.issn | 16775538 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16462 | |
dc.language.iso | English | |
dc.publisher | Brazilian Society of Urology | |
dc.rights | All Open Access; Gold Open Access; Green Open Access | |
dc.subject | Adolescent | |
dc.subject | Adult | |
dc.subject | Biomarkers, Tumor | |
dc.subject | Case-Control Studies | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Neoplasms, Germ Cell and Embryonal | |
dc.subject | Reference Values | |
dc.subject | Risk Factors | |
dc.subject | Spectrophotometry, Atomic | |
dc.subject | Statistics, Nonparametric | |
dc.subject | Testicular Neoplasms | |
dc.subject | Trace Elements | |
dc.subject | Young Adult | |
dc.subject | trace element | |
dc.subject | tumor marker | |
dc.subject | adolescent | |
dc.subject | adult | |
dc.subject | atomic absorption spectrometry | |
dc.subject | blood | |
dc.subject | case control study | |
dc.subject | human | |
dc.subject | male | |
dc.subject | Neoplasms, Germ Cell and Embryonal | |
dc.subject | nonparametric test | |
dc.subject | pathology | |
dc.subject | reference value | |
dc.subject | risk factor | |
dc.subject | Testicular Neoplasms | |
dc.subject | young adult | |
dc.title | Serum levels of trace elements in patients with testicular cancers | |
dc.type | Article |